Natalya Goloviznina

Dr. Natalya Goloviznina

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2015 in Scientific Reports
Verified
Journal Article
Open access
NHNoah I. Hornick
Noah I. Hornick
JHJianya Huan
Jianya Huan
BDBen Doron
Ben Doron
NGNatalya Goloviznina
Natalya Goloviznina
JLJodi Lapidus
Jodi Lapidus
PKPeter Kurre
Peter Kurre
Relapse remains the major cause of mortality for patients with Acute Myeloid Leukemia (AML). Improved tracking of minimal residual disease (MRD) holds the promise of timely treatment adjustments to preempt relapse. Current surveillance techniques detect circulating blasts that coincide with advanced disease and poorly reflect MRD during early relapse. Here, we investigate exosomes as a minimally invasive platform for a microRNA (miRNA) biomarker. We identify a set of miRNA enriched in AML exosomes and track levels of circulating exosome miRNA that distinguish leukemic xenografts from both non-engrafted and human CD34+ controls. We develop biostatistical models that reveal circulating exosomal miRNA at low marrow tumor burden and before circulating blasts can be detected. Remarkably, both leukemic blasts and marrow stroma contribute to serum exosome miRNA. We propose development of serum exosome miRNA as a platform for a novel, sensitive compartment biomarker for prospective tracking and early detection of AML recurrence.

15 January 2013 in Cancer Research
Verified
Journal Article
Closed access
PDF file
JHJianya Huan
Jianya Huan
NHNoah I. Hornick
Noah I. Hornick
MSMatthew J. Shurtleff
Matthew J. Shurtleff
ASAmy M. Skinner
Amy M. Skinner
NGNatalya Goloviznina
Natalya Goloviznina
PKPeter Kurre
Peter Kurre
Extrinsic signaling cues in the microenvironment of acute myelogenous leukemia (AML) contribute to disease progression and therapy resistance. Yet, it remains unknown how the bone marrow niche in which AML arises is subverted to support leukemic persistence at the expense of homeostatic function. Exosomes are cell membrane–derived vesicles carrying protein and RNA cargoes that have emerged as mediators of cell–cell communication. In this study, we examined the role of exosomes in developing the AML niche of the bone marrow microenvironment, investigating their biogenesis with a focus on RNA trafficking. We found that both primary AML and AML cell lines released exosome-sized vesicles that entered bystander cells. These exosomes were enriched for several coding and noncoding RNAs relevant to AML pathogenesis. Furthermore, their uptake by bone marrow stromal cells altered their secretion of growth factors. Proof-of-concept studies provided additional evidence for the canonical functions of the transferred RNA. Taken together, our findings revealed that AML exosome trafficking alters the proliferative, angiogenic, and migratory responses of cocultured stromal and hematopoietic progenitor cell lines, helping explain how the microenvironmental niche becomes reprogrammed during invasion of the bone marrow by AML. Cancer Res; 73(2); 918–29. ©2012 AACR.

1 March 2015 in Cancer Cell
Verified
Journal Article
Closed access
HGHuimin Geng
Huimin Geng
CHChristian Hurtz
Christian Hurtz
KLKyle B. Lenz
Kyle B. Lenz
ZCZhengshan Chen
Zhengshan Chen
DBDirk Baumjohann
Dirk Baumjohann
MMMarkus Müschen
Markus Müschen

25 June 2015 in Leukemia
Verified
Journal Article
Closed access
PDF file
JHJ Huan
J Huan
NHN I Hornick
N I Hornick
NGNatalya Goloviznina
Natalya Goloviznina
ALA N Kamimae- Lanning
A N Kamimae- Lanning
LDL L David
L L David
PKP Kurre
P Kurre

24 March 2010 in Journal of Experimental Botany
Verified
Journal Article
Open access
PDF file
RMRuth C. Martin
Ruth C. Martin
PLP.-P. Liu
P.-P. Liu
NGNatalya Goloviznina
Natalya Goloviznina
HNHiroyuki Nonogaki
Hiroyuki Nonogaki
MicroRNAs (miRNAs) are small, single-stranded RNAs that down-regulate target genes at the post-transcriptional level. miRNAs regulate target genes by guiding mRNA cleavage or by repressing translation. miRNAs play crucial roles in a broad range of developmental processes in plants. Multiple miRNAs are present in germinating seeds and seedlings of Arabidopsis, some of which are involved in the regulation of germination and seedling growth by plant hormones such as abscisic acid (ABA) and auxin. The involvement of miRNAs in ABA responses is not limited to the early stages of plant development but seems to be important for general stress responses throughout the plant life cycle. This Darwin review summarizes recent progress in miRNA research focusing on seed and stress biology, two topics which were of interest to Charles Darwin.

1 January 2015 in Molecular Metabolism
Verified
Journal Article
Open access
AKAshley N. Kamimae-Lanning
Ashley N. Kamimae-Lanning
SKStephanie M. Krasnow
Stephanie M. Krasnow
NGNatalya Goloviznina
Natalya Goloviznina
XZXinxia Zhu
Xinxia Zhu
QRQuinn R. Roth-Carter
Quinn R. Roth-Carter
DMdaniel marks
daniel marks
Recent evidence indicates that the adult hematopoietic system is susceptible to diet-induced lineage skewing. It is not known whether the developing hematopoietic system is subject to metabolic programming via in utero high-fat diet (HFD) exposure, an established mechanism of adult disease in several organ systems. We previously reported substantial losses in offspring liver size with prenatal HFD. As the liver is the main hematopoietic organ in the fetus, we asked whether the developmental expansion of the hematopoietic stem and progenitor cell (HSPC) pool is compromised by prenatal HFD and/or maternal obesity. We used quantitative assays, progenitor colony formation, flow cytometry, transplantation, and gene expression assays with a series of dietary manipulations to test the effects of gestational high-fat diet and maternal obesity on the day 14.5 fetal liver hematopoietic system. Maternal obesity, particularly when paired with gestational HFD, restricts physiological expansion of fetal HSPCs while promoting the opposing cell fate of differentiation. Importantly, these effects are only partially ameliorated by gestational dietary adjustments for obese dams. Competitive transplantation reveals compromised repopulation and myeloid-biased differentiation of HFD-programmed HSPCs to be a niche-dependent defect, apparent in HFD-conditioned male recipients. Fetal HSPC deficiencies coincide with perturbations in genes regulating metabolism, immune and inflammatory processes, and stress response, along with downregulation of genes critical for hematopoietic stem cell self-renewal and activation of pathways regulating cell migration. Our data reveal a previously unrecognized susceptibility to nutritional and metabolic developmental programming in the fetal HSPC compartment, which is a partially reversible and microenvironment-dependent defect perturbing stem and progenitor cell expansion and hematopoietic lineage commitment.